Leonard Wossnig is CTO at LabGenius where he leads a team of Data Scientists, Software Engineers, and Automation Experts to enhance LabGenius’ data-driven platform capabilities. 

He is an active academic contributor as an Honorary Research Fellow in Computer Science at UCL.

Prior to LabGenius, Leonard was VP of AI at Odyssey Therapeutics, leading a team of machine learning experts to develop a computational platform for generative drug design in the areas of cancer and inflammation. Odyssey raised >$400M and was one of the fastest growing U.S. Biotechs in 2022.

In 2018, Leonard co-founded Rahko, a quantum machine learning company merging computational chemistry, ML, and quantum physics to drive a better understanding of drug behaviour. Rahko developed ML methods that can leverage small datasets in drug discovery and partnered with Pharma. Leonard led the company from inception to acquisition in 2021.

Leonard holds a PhD from UCL where he was a Google PhD fellow in Computer Science.